Rekha Chaubey

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms.

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms.

Journal: BMC cancer

Published: May 15, 2023

Increased Expression of NOTCH-1 and T Helper Cell Transcription Factors in Patients with Acquired Aplastic Anemia.

Increased Expression of NOTCH-1 and T Helper Cell Transcription Factors in Patients with Acquired Aplastic Anemia.

Journal: Iranian biomedical journal

Published: July 31, 2022

Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation.

Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation.

Journal: Indian journal of cancer

Published: August 10, 2020

Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR-ABL1: A report of four cases from India.

Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR-ABL1: A report of four cases from India.

Journal: South Asian journal of cancer

Published: May 10, 2019

Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India.

Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India.

Journal: South Asian journal of cancer

Published: May 10, 2019

Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India.

Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India.

Journal: Indian journal of pathology & microbiology

Published: April 12, 2019

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib.

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib.

Journal: South Asian journal of cancer

Published: November 16, 2018

Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient.

Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient.

Journal: Platelets

Published: November 30, 2017

NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective.

NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective.

Journal: Indian journal of pathology & microbiology

Published: September 23, 2017

Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.

Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.

Journal: Annals of diagnostic pathology

Published: September 19, 2016

C1236T polymorphism in MDR1 gene correlates with therapeutic response to imatinib mesylate in Indian patients with chronic myeloid leukaemia.

C1236T polymorphism in MDR1 gene correlates with therapeutic response to imatinib mesylate in Indian patients with chronic myeloid leukaemia.

Journal: The National medical journal of India

Published: June 14, 2016

Does Indian Myelodysplastic Syndrome Have a Biology Different from That in the West ?

Does Indian Myelodysplastic Syndrome Have a Biology Different from That in the West ?

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 26, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026